Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0412198Aexternal-prioritypatent/GB0412198D0/en
Application filed by 7Tm Pharma AsfiledCritical7Tm Pharma As
Publication of ECSP067115ApublicationCriticalpatent/ECSP067115A/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
230000000694effectsEffects0.000abstract1
206010039083rhinitisDiseases0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Los compuestos de la fórmula (I) son útiles para el tratamiento de enfermedad senciblea la modulación de actividad de receptor CRTH2, tales como es asma, rinitis, síndrome alérgico de vías aéreas y ridobronquitis alérgica.The compounds of the formula (I) are useful for the treatment of sencible disease modulating CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome and allergic ridobronchitis.
ECSP0671152004-05-292006-12-26
MEDICAL USE OF RECEIVING LINGADOS
ECSP067115A
(en)
2,3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETHYL DERIVATIVES AS AN ALPHA2S ANTAGONISTS FOR THE APPLICATION IN THE TREATMENT OF DISEASES OF THE CIRCULAR NERVOUS SYSTEM
Compounds derived from tropane urea, modulators of the activity of 11betahsd1; preparation procedure; pharmaceutical composition; and use for the treatment of diseases such as obesity, diabetes, hypertension, atherosclerosis, dementia and osteoporosis.
Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others.
Compounds derived from imidazopyrimidine, substituted, pde10a inhibitors; preparation procedure; pharmaceutical composition; and its use for the treatment or prevention of psychotic disorders, schizophrenia, parkinson's disease, multiple sclerosis, among others.
Compounds derived from substituted quinazolinediones, pde7 and pde8 inhibitors; pharmaceutical composition comprising them; procedure for preparing these; and uses in the treatment and / or prevention of inflammatory, immune-inflammatory, gi, bone, cancer, among others.
Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.